HK1022265A1 - Biodegradable microparticles for the sustained delivery of therapeutic drugs - Google Patents

Biodegradable microparticles for the sustained delivery of therapeutic drugs

Info

Publication number
HK1022265A1
HK1022265A1 HK00101153A HK00101153A HK1022265A1 HK 1022265 A1 HK1022265 A1 HK 1022265A1 HK 00101153 A HK00101153 A HK 00101153A HK 00101153 A HK00101153 A HK 00101153A HK 1022265 A1 HK1022265 A1 HK 1022265A1
Authority
HK
Hong Kong
Prior art keywords
sustained delivery
therapeutic drugs
biodegradable microparticles
relates
present
Prior art date
Application number
HK00101153A
Other languages
English (en)
Inventor
Subodh Shah
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/843,975 external-priority patent/US6020004A/en
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of HK1022265A1 publication Critical patent/HK1022265A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
HK00101153A 1997-04-17 2000-02-25 Biodegradable microparticles for the sustained delivery of therapeutic drugs HK1022265A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/843,975 US6020004A (en) 1997-04-17 1997-04-17 Biodegradable microparticles for the sustained delivery of therapeutic drugs
US6166598A 1998-04-16 1998-04-16
PCT/US1998/007856 WO1998046212A1 (fr) 1997-04-17 1998-04-17 Microparticules biodegradables pour administration soutenue de medicaments therapeutiques

Publications (1)

Publication Number Publication Date
HK1022265A1 true HK1022265A1 (en) 2000-08-04

Family

ID=26741350

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00101153A HK1022265A1 (en) 1997-04-17 2000-02-25 Biodegradable microparticles for the sustained delivery of therapeutic drugs

Country Status (11)

Country Link
EP (1) EP0975334B1 (fr)
JP (1) JP2002514215A (fr)
AT (1) ATE252375T1 (fr)
AU (1) AU7134898A (fr)
CA (1) CA2287534C (fr)
DE (1) DE69819145T2 (fr)
DK (1) DK0975334T3 (fr)
ES (1) ES2205481T3 (fr)
HK (1) HK1022265A1 (fr)
PT (1) PT975334E (fr)
WO (1) WO1998046212A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3645906B2 (ja) 1993-11-19 2005-05-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ マイクロカプセル封入された３−ピペリジニル−置換１，２−ベンズイソオキサゾール類及び１，２−ベンズイソチアゾール類
US6291013B1 (en) 1999-05-03 2001-09-18 Southern Biosystems, Inc. Emulsion-based processes for making microparticles
AU1226901A (en) * 1999-10-22 2001-05-08 Amgen, Inc. Biodegradable microparticles with novel erythropoietin stimulating protein
CA2397404C (fr) * 2000-01-14 2008-12-02 Brown University Research Foundation Particules lyophilisees microfines
US7029700B2 (en) 2000-01-14 2006-04-18 Brown University Research Foundation Micronized freeze-dried particles
JP2004534721A (ja) * 2000-10-31 2004-11-18 ピーアール ファーマシューティカルズ，インク． 生理活性分子の向上した送達のための方法及び組成物
WO2003092585A2 (fr) * 2002-05-02 2003-11-13 Pr Pharmaceuticals, Inc. Compositions a liberation regulee de metabolites d'estradiol
EP1829529A1 (fr) * 2002-05-03 2007-09-05 PR Pharmaceuticals, Inc. Compositions à libération contrôlée de métabolites d'éstradiol
DK2599502T3 (en) 2003-04-11 2017-04-18 Antriabio Inc Process for Preparation of Site-Specific Protein Conjugates
DK1765294T3 (da) 2004-05-12 2008-11-10 Baxter Int Nukleinsyremikrokugler samt deres fremstilling og afgivelse
US7884085B2 (en) 2004-05-12 2011-02-08 Baxter International Inc. Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
EP1679065A1 (fr) * 2005-01-07 2006-07-12 OctoPlus Sciences B.V. Formulation destinée à la libération contrôlée d'interferone par un copolymère bloc PEGT/PBT
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
JP5118139B2 (ja) 2006-08-04 2013-01-16 バクスター・インターナショナル・インコーポレイテッド 新規発症自己免疫性糖尿病を予防および／または逆転させるためのマイクロスフィアに基づく組成物
MX2009011218A (es) 2007-04-17 2010-02-11 Baxter Int Microparticulas de acido nucleico para administracion pulmonar.
BRPI0912536A2 (pt) * 2008-05-06 2018-10-16 Glaxo Group Ltd método para produzir um carregador particulado, carreador particulado, composição farmacêutica, e, e uso da mesma.
US20110311630A1 (en) * 2008-06-09 2011-12-22 Boehringer Ingelheim International Gmbh Novel embedment particles for inhalation
KR20100037389A (ko) * 2008-10-01 2010-04-09 연세대학교 산학협력단 다중 약물방출조절이 가능한 솔리드 마이크로구조체 및 이의 제조방법
AU2017300392B2 (en) * 2016-07-18 2022-06-16 Tissuegen, Inc. Methods and compositions for maintaining the conformation and structural integrity of biomolecules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6058915A (ja) * 1983-09-12 1985-04-05 Fujisawa Pharmaceut Co Ltd 薬物含有脂質小胞体製剤
JP2653255B2 (ja) * 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
WO1996022786A1 (fr) * 1995-01-23 1996-08-01 Takeda Chemical Industries, Ltd. Preparation a diffusion prolongee et son emploi

Also Published As

Publication number Publication date
PT975334E (pt) 2004-03-31
DE69819145D1 (de) 2003-11-27
EP0975334A1 (fr) 2000-02-02
CA2287534A1 (fr) 1998-10-22
WO1998046212A1 (fr) 1998-10-22
JP2002514215A (ja) 2002-05-14
EP0975334B1 (fr) 2003-10-22
AU7134898A (en) 1998-11-11
CA2287534C (fr) 2004-12-28
DE69819145T2 (de) 2004-08-19
ES2205481T3 (es) 2004-05-01
DK0975334T3 (da) 2004-01-19
ATE252375T1 (de) 2003-11-15

Similar Documents

Publication Publication Date Title
HK1022265A1 (en) Biodegradable microparticles for the sustained delivery of therapeutic drugs
IL140930A0 (en) Compounds and compositions for delivering active agents
EP1015008A4 (fr) Composes et compositions destines a l'administration d'agents actifs
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
ATE387430T1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
HK1054918A1 (en) Compounds and compositions for delivering active agents
HK1036970A1 (en) Compounds and compositions for delivering active agents.
EP0783299A4 (fr) Composes et compositions pour l'administration d'agents actifs
FI962154A (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
EP1233756A4 (fr) Excipients solides pour administration amelioree d'ingredients actifs contenus dans des compositions pharmaceutiques
HK1048801A1 (en) Phenoxy carboxylic acid compounds and compositions for delivering active agents
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
AU3492100A (en) Oxadiazole compounds and compositions for delivering active agents
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
WO2002015959A3 (fr) Composes et compositions permettant de distribuer des agents actifs
MY140724A (en) Novel arylethene-sulfonamides
MY138502A (en) Novel alkansulfonamides as endothelin antagonists
EP0817643A4 (fr) Composes et compositions servant a l'apport d'agents actifs
EP1676832A3 (fr) Composés et compositions pour la délivrance d'agents actifs

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090417